IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i22p4585-d288679.html
   My bibliography  Save this article

Trends in Opioid Misuse among Marijuana Users and Non-Users in the U.S. from 2007–2017

Author

Listed:
  • Sunday Azagba

    (Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA)

  • Lingpeng Shan

    (Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA)

  • Lauren Manzione

    (Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA)

  • Fares Qeadan

    (Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA)

  • Mark Wolfson

    (Department of Social Medicine, Population and Public Health, University of California, Riverside School of Medicine, Riverside, CA 92501, USA)

Abstract

Prescription-opioid misus e continues to be a significant health concern in the United States. The relationship between marijuana use and prescription-opioid misuse is not clear from the extant literature. This study examined national trends in prescription-opioid misuse among marijuana users and non-users using the 2007–2017 National Survey on Drug Use and Health. Cochran–Armitage tests were used to assess the statistical significance of changes in the yearly prevalence of prescription-opioid misuse and marijuana use. Multivariable logistic regression was used to examine the association between prescription-opioid and marijuana use adjusting for sociodemographic characteristics. From 2007 to 2017, marijuana use increased, while prescription-opioid misuse declined. Larger declines in prescription-opioid misuse were found among marijuana users than non-users. Marijuana ever-use was significantly associated with prescription-opioid misuse. Specifically, marijuana ever-users had higher odds of prescription-opioid misuse (ever-misuse [OR: 3.04; 95% CI, 2.68–3.43]; past-year misuse [OR: 3.44; 95% CI, 3.00–3.94]; and past-month misuse [OR: 4.50; 95% CI, 3.35–6.05]) compared to marijuana never-users. Similar results were found for the association of past-year and past-month marijuana use with prescription-opioid misuse. This study provides data on trends and associations about opioid misuse among marijuana users and non-users in a changing social environment of drug use in the United States. Future research should consider whether there is a causal relationship between marijuana use and prescription opioid misuse.

Suggested Citation

  • Sunday Azagba & Lingpeng Shan & Lauren Manzione & Fares Qeadan & Mark Wolfson, 2019. "Trends in Opioid Misuse among Marijuana Users and Non-Users in the U.S. from 2007–2017," IJERPH, MDPI, vol. 16(22), pages 1-11, November.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:22:p:4585-:d:288679
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/22/4585/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/22/4585/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Chelsea L. Shover & Corey S. Davis & Sanford C. Gordon & Keith Humphreys, 2019. "Association between medical cannabis laws and opioid overdose mortality has reversed over time," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, vol. 116(26), pages 12624-12626, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cornelius A. Rietveld & Pankaj C. Patel, 2021. "Prescription opioids and new business establishments," Small Business Economics, Springer, vol. 57(3), pages 1175-1199, October.
    2. Cheng, Stephanie F. & De Franco, Gus & Lin, Pengkai, 2023. "Marijuana liberalization and public finance: A capital market perspective on the passage of medical use laws," Journal of Accounting and Economics, Elsevier, vol. 75(1).
    3. Coleman Drake & Jiebing Wen & Jesse Hinde & Hefei Wen, 2021. "Recreational cannabis laws and opioid‐related emergency department visit rates," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2595-2605, September.
    4. Cornelius A. Rietveld & Pankaj C. Patel, 0. "Prescription opioids and new business establishments," Small Business Economics, Springer, vol. 0, pages 1-25.
    5. Shyam Raman & Ashley C. Bradford, 2022. "Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees," Health Economics, John Wiley & Sons, Ltd., vol. 31(7), pages 1513-1521, July.
    6. Dmitry Arkhangelsky & Guido W. Imbens & Lihua Lei & Xiaoman Luo, 2021. "Design-Robust Two-Way-Fixed-Effects Regression For Panel Data," Papers 2107.13737, arXiv.org, revised Mar 2024.
    7. Marinello, Samantha & Powell, Lisa M., 2023. "The impact of recreational cannabis markets on motor vehicle accident, suicide, and opioid overdose fatalities," Social Science & Medicine, Elsevier, vol. 320(C).
    8. Sam Parsons & Ingrid Schoon & Emla Fitzsimons, 2022. "Evidence from the UK Millennium Cohort Study. Teenage children of mothers who experienced out-of-home care: How are they doing?," DoQSS Working Papers 22-08, Quantitative Social Science - UCL Social Research Institute, University College London.
    9. Anderson, D. Mark & Rees, Daniel I., 2021. "The Public Health Effects of Legalizing Marijuana," IZA Discussion Papers 14292, Institute of Labor Economics (IZA).
    10. Junxing Chay & Seonghoon Kim, 2022. "Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 269-283, February.
    11. Mathur, Neil K. & Ruhm, Christopher J., 2023. "Marijuana legalization and opioid deaths," Journal of Health Economics, Elsevier, vol. 88(C).
    12. Grant W. Neeley & Lilliard E. Richardson Jr., 2022. "Marijuana Policy Bundles in the American States Over Time and Their Impact on the Use of Marijuana and Other Drugs," Evaluation Review, , vol. 46(2), pages 165-199, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:22:p:4585-:d:288679. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.